AstraZeneca and Saint Lukes Mid America Heart Institute initiate Phase III DARE-19 trial with Farxiga in COVID-19 patients
PressReleasePoint,
Trial will assess the potential of Farxiga in reducing the risk of serious complications and organ failure AstraZeneca and…